Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026)

Dr Reddys Laboratories' Long-Term Investments history runs 11 years deep, the most recent figure standing at $114.0 million for Q1 2026.

• On a quarterly basis, Long-Term Investments rose 103.57% year-over-year to $114.0 million in Q1 2026; TTM through Mar 2026 was $114.0 million, a 103.57% increase from a year earlier, with the FY2026 full-year figure at $114.0 million, up 103.57% from the prior year.
• Long-Term Investments advanced to $114.0 million in Q1 2026 per RDY's latest filing, from $56.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $114.0 million in Q1 2026 and bottomed at $8.0 million in Q1 2023.
• The 5-year median for Long-Term Investments is $56.0 million (2025), against an average of $49.6 million.
• Across the five-year window, Long-Term Investments tumbled 85.96% in 2023 and surged 330.77% in 2025, its largest moves.
• Year by year, Long-Term Investments stood at $57.0 million in 2022, then tumbled by 85.96% to $8.0 million in 2023, then surged by 62.5% to $13.0 million in 2024, then jumped by 330.77% to $56.0 million in 2025, then soared by 103.57% to $114.0 million in 2026.
• Per Business Quant, the three latest RDY Long-Term Investments figures stand at $114.0 million (Q1 2026), $56.0 million (Q1 2025), and $13.0 million (Q1 2024).